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Abstract. Predicting TNM stage is the major determinant of breast
cancer prognosis and treatment. The essential part of TNM stage clas-
sification is whether the cancer has metastasized to the regional lymph
nodes (N-stage). Pathologic N-stage (pN-stage) is commonly performed
by pathologists detecting metastasis in histological slides. However, this
diagnostic procedure is prone to misinterpretation and would normally
require extensive time by pathologists because of the sheer volume of
data that needs a thorough review. Automated detection of lymph node
metastasis and pN-stage prediction has a great potential to reduce their
workload and help the pathologist. Recent advances in convolutional neu-
ral networks (CNN) have shown significant improvements in histological
slide analysis, but accuracy is not optimized because of the difficulty
in the handling of gigapixel images. In this paper, we propose a robust
method for metastasis detection and pN-stage classification in breast
cancer from multiple gigapixel pathology images in an effective way.
pN-stage is predicted by combining patch-level CNN based metastasis
detector and slide-level lymph node classifier. The proposed framework
achieves a state-of-the-art quadratic weighted kappa score of 0.9203 on
the Camelyon17 dataset, outperforming the previous winning method of
the Camelyon17 challenge.
Keywords: Camelyon17, Convolutional neural networks, Deep learn-
ing, Metastasis detection, pN-stage classification, Breast cancer
1 Introduction
When cancer is first diagnosed, the first and most important step is staging of the
cancer by using the TNM staging system [1], the most commonly used system.
Invasion to lymph nodes, highly predictive of recurrence [2], is evaluated by
pathologists (pN-stage) via detection of tumor lesions in lymph node histology
slides from a surgically resected tissue. This diagnostic procedure is prone to
misinterpretation and would normally require extensive time by pathologists
because of the sheer volume of data that needs a thorough review. Automated
detection of lymph node metastasis and pN-stage prediction has the potential
to significantly elevate the efficiency and diagnostic accuracy of pathologists for
one of the most critical diagnostic process of breast cancer.
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In the last few years, considerable improvements have been emerged in the
computer vision task using CNN [3]. Followed by this paradigm, CNN based com-
puter assisted metastasis detection has been proposed in recent years [4,5,6].
However, recent approaches metastasis detection in whole slide images have
shown the difficulty in handling gigapixel images [4,5,6]. Furthermore, pN-stage
classification requires handling multiple gigapixel images.
In this paper, we introduce a robust method to predict pathologic N-stage
(pN-stage) from whole slide pathology images. For the robust performance, we
effectively handle multiple gigapixel images in order to integrate CNN into pN-
stage prediction framework such as balanced patch sampling, patch augmenta-
tion, stain color augmentation, 2-stage fine-tuning and overlap tiling strategy.
We achieved patient-level quadratic weighted kappa score 0.9203 on the Came-
lyon17 test set which it yields the new state-of-the-art record on Camelyon17
leaderboard [7].
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Fig. 1. Overall architecture of our pN-stage prediction framework.
2 Methodology
Fig. 1 shows the overall scheme of our proposed framework. First, ROI extraction
module proposes candidate tissue regions from whole slide images. Second, CNN-
based metastasis detection module predicts cancer metastasis within extracted
ROIs. Third, the predicted scores extracted from ROI are converted to a feature
vector based on the morphological and geometrical information which is used to
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build a slide-level lymph node classifier. Patient-level pN-stage is determined by
aggregating slide-level predictions with given rules [7].
2.1 Regions of Interests Extraction
A whole slide image (WSI) is approximately 200000×100000 pixels on the highest
resolution level. Accurate tissue region extraction algorithms can save compu-
tation time and reduce false positives from noisy background area. In order to
extract tissue regions from the WSIs, Otsu threshold [8] or gray value threshold
is commonly used in recent studies [4,5,6]. We decide to use gray value threshold
method which shows superior performance in our experiments.
2.2 Metastasis Detection
Some annotated metastasis regions include non-metastasis area since accurate
pixel-level annotation is difficult in gigapixel WSIs [5]. We build a large scale
dataset by extracting small patches from WSIs to deal with those noisy labels.
After the ROIs are found from WSIs as described in Section 2.1, we extract
256×256 patches within ROIs with stride 128 pixels. We label a patch as tumor if
over 75% pixels in the patch are annotated as a tumor. Our metastasis detection
module is based on the well-known CNN architecture ResNet101 [3] for patch
classification to discriminate between tumor and non-tumor patches.
Although the proposed method seems straightforward, we need to effectively
handle gigapixel WSIs to integrate CNN into pN-stage prediction framework for
the robust performance, as described below.
Balanced Patch Sampling The areas corresponding to tumor regions often
covered only a minor proportion of the total slide area, contributing to a large
patch-level imbalance. To deal with this imbalance, we followed similar patch
sampling approach used in [5]. In detail, we sample the same number of tu-
mor/normal patches where patches are sampled from each slide with uniform
distribution.
Table 1. Patch augmentation details.
Methods Details
Translation random x, y offset in [-8, 8]
Left/right flip with 0.5 probability
Rotation random angle in [0, 360)
Patch Augmentation There are only
400 WSIs in Camelyon16 dataset and 500
WSIs in Camelyon17 train set. Patches
sampled from same WSI exhibit similar
data property, which is prone to overfit-
ting. We perform extensive data augmentation at the training step to overcome
small number of WSIs. Since the classes of histopathology image exhibit ro-
tational symmetry, we include patch augmentation by randomly rotating over
angles between 0 and 360, and random left-right flipping. Details are shown in
Table 1.
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Table 2. Stain color augmentation details.
Methods Details
Hue random delta in [-0.04, 0.04]
Saturation random saturation factor in [0.75, 1.25]
Brightness random delta in [-0.25, 0.25]
Contrast random contrast factor in [0.25, 1.75]
Stain Color Augmentation To
combat the variety of hematoxylin and
eosin (H&E) stained color because
of chemical preparation difference per
slide, extensive color augmentation is
performed by applying random hue, saturation, brightness, and contrast as de-
scribed in Table 2. CNN model becomes robust against stain color variety by
applying stain color augmentation at the training step.
2-Stage Fine-Tuning Camelyon16 and Camelyon17 dataset are collected from
different medical centers. Each center may use different slide scanners, different
scanning settings, difference tissue staining conditions. We handle this multi-
center variation by applying the 2-stage fine-tuning strategy. First, we fine-tune
CNN with the union set of Camelyon16 and Camelyon17 and then fine-tune
CNN again with only Camelyon17 set. The fine-tuned model becomes robust
against multi-center variation between Camelyon16 and Camelyon17 set.
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Fig. 2. Tiling strategy for dense heatmap. (a)
A ground truth; (b) Straightforward tiling
strategy; (c) Overlap-tile strategy.
Overlap Tiling Strategy In
the prediction stage, probabil-
ity heatmap is generated by the
trained CNN based metastasis de-
tector. A straightforward way to
generate a heatmap from WSI is
separating WSI into patch size
tiles and merging patch level pre-
dictions from each tile. However,
this simple strategy provides in-
sufficient performance. Instead, we
use similar overlap-tile strategy [9]
for dense heatmap from tiled WSI.
As shown in Fig. 2, the probabil-
ity heatmap generated by overlap-
tile strategy provides denser heatmap than straightforward tiling strategy even
though the same classifier is used. By default, we used 50% overlapped tiles
shown in Fig. 2(c).
2.3 Lymph Node Classification
To determine each patient’s pN-stage, multiple lymph node slides should be clas-
sified into four classes (Normal, Isolated tumor cells (ITC), Micro, Macro). For each
lymph node WSI, we obtain the 128× down-sampled tumor probability heatmap
through the CNN based metastasis detector (Section 2.2). Each heatmap is con-
verted into a feature vector which is used to build a slide level lymph node
classifier. We define 11 types of features based on the morphological and geo-
metrical information. By using converted features, random forest classifier [10]
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is trained to automatically classify the lymph node into four classes. Finally,
each patient’s pN-stage is determined by aggregating all lymph node predictions
with the given rule [7]. We followed the Camelyon17’s simplified version of the
pN-staging system (pN0, pN0(i+), pN1mi, pN1, pN2) [7].
3 Experiments
3.1 Dataset
We evaluate our framework on Camelyon16 [6] and Camelyon17 [7] dataset.
The Camelyon16 dataset contains 400 WSIs with region annotations for all its
metastasis slides. The Camelyon17 dataset contains 1000 WSIs with 5 slides per
patient: 500 slides for the train set, 500 slides for the test set. The train set
consists of the slide level metastasis annotation. There are 3 categories of lymph
node metastasis: Macro (Metastases greater than 2.0 mm), Micro (metastasis greater
than 0.2 mm or more than 200 cells, but smaller than 2.0 mm), and ITC (single tumor
cells or a cluster of tumor cells smaller than 0.2mm or less than 200 cells).
Table 3. Details of our Camelyon17 dataset split.
Dataset
# of patients per each pN-stage
pN0 pN0(i+) pN1mi pN1 pN2 Total
Camelyon17 train-M 0 9 11 14 9 43
Camelyon17 train-L 24 3 9 11 10 57
Dataset
# of patients per each medical center
Center1 Center2 Center3 Center4 Center5 Total
Camelyon17 train-M 7 8 9 10 9 43
Camelyon17 train-L 13 12 11 10 11 57
Dataset
# of WSIs per each metastasis type
Negative ITC Micro Macro Total
Camelyon17 train-M 110 26 35 44 215
Camelyon17 train-L 203 9 29 44 285
Since the Camelyon17 set
provides only 50 slides with
lesion-level annotations in train
set, we split 100 patients (to-
tal 500 WSIs since each pa-
tient provides 5 WSIs) into
43 patients for the Came-
lyon17 train-M set to train
metastasis detection module,
57 patients for the Came-
lyon17 train-L set to train lymph node classification module. In detail, if pa-
tient’s any slide include lesion-level annotation, we allocate that patient as a
Camelyon17 train-M set. Other patients are allocated as a Camelyon17 train-L
set. As shown in Table 3, our split strategy separates similar data distribution
between them in terms of the medical centers and metastasis types.
3.2 Evaluation Metrics
Metastasis Detection Evaluation We used the Camelyon16 evaluation met-
ric [6] on the Camelyon16 dataset to validate metastasis detection module per-
formance. Camelyon16 evaluation metric consists of two metrics, the area under
receiver operating characteristic (AUC) to evaluate the slide-level classification
and the FROC to evaluate the lesion-level detection and localization.
pN-stage Classification Evaluation To evaluate pN-stage classification, we
used the Camelyon17 evaluation metric [7], patient-level five-class quadratic
weighted kappa where the classes are the pN-stages. Slide-level lymph node clas-
sification accuracy is also measured to validate lymph node classification module
performance.
6 Byungjae Lee, Kyunghyun Paeng
3.3 Experimental Details
ROI Extraction Module For the type of ROI extraction between Otsu thresh-
old and gray value threshold, we determined to use gray value threshold method
which is obtained a better performance on Camelyon16 train set. In detail,
we convert RGB to gray from 32× down-sampled WSI and then extract tissue
regions by thresholding gray value > 0.8.
Table 4. Number of training WSIs for
metastasis detection module.
Training data # of tumor slides # of normal slides
Camelyon16 train 110 160
Camelyon16 test 50 80
Camelyon17 train-M 50* 110
* only 50 slides include region annotations from total
105 tumor slides in Camelyon17 train-M set
Metastasis Detection Module Dur-
ing training and inference, we ex-
tracted 256×256 patches from WSIs
at the highest magnification level of
0.243 µm/pixel resolution. For training
of the patch-level CNN based classifier,
400 WSIs from Camelyon16 dataset
and 160 WSIs from Camelyon17 train set are used as shown in Table 4. Total
1,430K tumor patches and 43,700K normal patches are extracted.
We trained ResNet101 [3] with initial parameters from ImageNet pretrained
model to speed up convergence. We updated batch normalization parameters
during fine-tuning because of the data distribution difference between the Im-
ageNet dataset and the Camelyon dataset. We used the Adam optimization
method with a learning rate 1e-4. The network was trained for approximately 2
epoch (500K iteration) with a batch size 32 per GPU.
To find hyperparameters and validate performance, we split Camelyon16
train set into our train/val set, 80% for train and 20% for validation. For AUC
evaluation, we used maximum confidence probability in WSI. For FROC eval-
uation, we followed connected component approach [11] which find connected
components and then report maximum confidence probability’s location within
the component. After hyperparameter tuning, we finally train CNN with all
given training dataset in Table 4.
Table 5. Feature components for predicting lymph node metastasis type.
No. Feature description No. Feature description
1 largest region’s major axis length 7 maximum confidence probability in WSI
2 largest region’s maximum confidence probability 8 average of all confidence probability in WSI
3 largest region’s average confidence probability 9 number of regions in WSI
4 largest region’s area 10 sum of all foreground area in WSI
5 average of all region’s averaged confidence probability 11 foreground and background area ratio in WSI
6 sum of all region’s area
Lymph Node Classification Module We generated the tumor probabil-
ity heatmap from WSI using the metastasis detection module. For the post-
processing, we thresholded the heatmap with a threshold of t = 0.9. We found
hyperparameters and feature designs for random forest classifier in Camelyon17
train-L set with 5-fold cross-validation setting. Finally, we extracted 11 features
described in Table 5. We built a random forest classifier to discriminate lymph
node classes using extracted features. Each patient’s pN-stage was determined
by the given rule [7] with the 5 lymph node slide prediction result.
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3.4 Results
Table 6. Metastasis detection results
on Camelyon16 test set
Method
Ense-
mble
AUC FROC
Lunit Inc. 0.985 0.855
Y. Liu et al. ensmeble-of-3 [5] X 0.977 0.885
Y. Liu et al. 40X [5] 0.967 0.873
Harvard & MIT [11] X 0.994 0.807
Pathologist* [6] - 0.966 0.724
* expert pathologist who assessed without a time
constraint
Metastasis Detection on Came-
lyon16 We validated our metastasis
detection module on the Camelyon16
dataset. For the fair comparison with
the state-of-the-art methods, our model
is trained on the 270 WSIs from Came-
lyon16 train set and evaluated on the
130 WSIs from Camelyon16 test set us-
ing the same evaluation metrics provided
by the Camelyon16 challenge. Table 6 summarizes slide-level AUC and lesion-
level FROC comparisons with the best previous methods. Our metastasis de-
tection module achieved highly competitive AUC (0.9853) and FROC (0.8552)
without bells and whistles.
Table 7. Top-10 pN-stage classification result on the Camelyon17 leaderboard [7]. The
kappa score is evaluated by the Camelyon17 organizers. Accessed: 2018-03-02.
Team Affiliation
Kappa
score
Lunit Inc.* Lunit Inc. 0.9203
HMS-MGH-CCDS Harvard Medical School, Mass. General Hospital, Center for Clinical Data Science 0.8958
DeepBio* Deep Bio Inc. 0.8794
VCA-TUe Electrical Engineering Department, Eindhoven University of Technology 0.8786
JD* JD.com Inc. - PCL Laboratory 0.8722
MIL-GPAT The Univercity of Tokyo, Tokyo Medical and Dental University 0.8705
Indica Labs Indica Labs 0.8666
chengshenghua* Huazhong University of Science and Technology, Britton Chance Center for Biomedical Photonics 0.8638
Mechanomind* Mechanomind 0.8597
DTU Technical University of Denmark 0.8244
* Submitted result after reopening the challenge
pN-stage Classification on Camelyon17 For validation, we first evaluated
our framework on Camelyon17 train-L set with 5-fold cross-validation setting.
Our framework achieved 0.9351 slide-level lymph node classification accuracy
and 0.9017 patient-level kappa score using single CNN model in metastasis de-
tection module. We trained additional CNN models with different model hyper-
parameters and fine-tuning setting. Finally, three model was ensembled by av-
eraging probability heatmap and reached 0.9390 slide-level accuracy and 0.9455
patient-level kappa score with the 5-fold cross-validation.
Next, we evaluated our framework on the Camelyon17 test set and the kappa
score has reached 0.9203. As shown in Table 7, our proposed framework signif-
icantly outperformed the state-of-the-art approaches by large-margins where it
achieves better performance than the previous winning method (HMS-MGH-
CCDS) of the Camelyon17 challenge.
Furthermore, the accuracy of our algorithm not only exceeded that of current
leading approaches (bold black color in Table 8) but also significantly reduced
false-negative results (red color in Table 8). This is remarkable from a clinical
perspective, as false-negative results are most critical, likely to affect patient
survival due to consequent delay in diagnosis and appropriate timely treatment.
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Table 8. Slide-level lymph node classification confusion matrix comparison on the
Camelyon17 test set. The confusion matrix is generated by the Camelyon17 organizers.
Predicted
Negative ITC Micro Macro
R
ef
er
en
ce Negative 96.15% 3.08% 0.77% 0.00%
ITC 55.88% 11.76% 32.35% 0.00%
Micro 9.64% 2.41% 85.54% 2.41%
Macro 3.25% 0.00% 5.69% 91.06%
(a) Ours
Predicted
Negative ITC Micro Macro
R
ef
er
en
ce Negative 95.38% 0.38% 4.23% 0.00%
ITC 76.47% 14.71% 8.82% 0.00%
Micro 13.25% 1.20% 78.31% 7.23%
Macro 1.63% 0.00% 12.20% 86.18%
(b) HMS-MGH-CCDS
4 Conclusion
We have introduced a robust and effective method to predict pN-stage from
lymph node histological slides, using CNN based metastasis detection and ran-
dom forest based lymph node classification. Our proposed method achieved the
state-of-the-art result on the Camelyon17 dataset. In future work, we would like
to build an end-to-end learning framework for pN-stage prediction from WSIs.
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